About Us

Genomenon is a genomics intelligence company in the lead position to be the first to curate the entire human genome. Our team is dedicated to improving the quality of patients’ lives by characterizing the genomic drivers of genetic disease and cancer.

Blending the power of AI with the precision of genomic expertise, Genomenon simplifies complex genetic data into actionable insights for patient diagnosis and precision medicine development.

Genomenon, a name signifying “born out of need” in ancient Greek, perfectly encapsulates the genesis of our journey.

In his clinical practice and genomic research, co-founder Dr. Mark Kiel was frustrated with the painfully slow and time-consuming process of manual curation. He was also well aware of the diagnostic odyssey that thousands of rare disease patients and families face as he and his twin brother had hypodontia, or missing adult teeth, in their youth. Living with a rare condition as a child focused Mark’s attention on genetics and his desire to make an impact on rare diseases.

Genomenon was founded in 2014 to address this pressing need for faster, more comprehensive variant interpretation by combining expert curation with unique machine-learning methods designed to keep up with the pace of new publications and present the most relevant information to researchers.

Today, Genomenon empowers scientists, researchers and clinicians at pharmaceutical companies, clinical labs, and universities to more thoroughly understand diseases at a molecular level.

Genomenon is headquartered in Ann Arbor, Michigan.

Our Offerings Include


Mastermind is a cutting-edge software tool that leverages AI to analyze and interpret vast genomic datasets, offering unparalleled insights.


Gain access to an expansive, constantly updated database of curated genomic information. This resource is essential for informed research and clinical-decision making, offering a wealth of gene-disease associations and variant data.


Our expert team provides tailored consulting services to support your genomic projects. From custom variant analysis to clinical trial support and regulatory guidance, we ensure you have the expert insights needed for your specific genomic challenges.

Somatic Knowledgebase

The Clinical Knowledgebase is the standard in evidence-based interpretation of cancer genomic profiles.

Every accolade is a testament to our team and our mission to make genomic information actionable

Our Leadership Team

Working together to make genomic information actionable.

Mike Klein
Chief Executive Officer

With over 25 years of developing, building and growing 4 different high-tech companies, Mike raised over $50M in capital and had several successful investor exits.

Mark J. Kiel, MD, PhD
Chief Scientific Officer & Co-Founder

Mark has extensive experience in genome sequencing and clinical data analysis underlying the vision and technology driving the Genomenon suite of software tools.

Sean Kearney
Chief Financial Officer

Always seeking opportunities for growth, Sean has spent his career investing in and scaling innovative platforms in genomics, telemedicine and healthcare delivery.

Sam Globus, PhD
Chief Operating Officer

Sam brings a wealth of experience in genomic product development and operations to the team, and manages the rapid growth of our data science and variant curation work.

Brittnee Jones, PhD
Vice President of Product & Product Strategy

Brittnee has spent over a decade building and leading customer success teams across the NGS space, ensuring rapid product adaption and maximal value for customers.

Jon Murray
Vice President of Sales

Jon has been in the informatics market for over 25 years. He brings a track record of successful sales management and team building.

Colleen McMillen
Vice President of Marketing

Colleen is an accomplished communications and marketing executive in the health space with more than two decades of experience delivering high-impact positioning for products, organizations and executive teams.

Dave Anstey
Vice President of Pharma Business Development

Dave has almost 30 years of experience selling scientific software with a track record of building successful sales teams and meaningful customer relationships.

Jonathan Eads
Vice President of Engineering

Jonathan brings 25 years of experience in genomics, drug discovery, bioinformatics, and AI/ML software application development, with extensive experience building and leading engineering teams to deliver operational excellence.

Ronda Bergman
Director of Engineering

Ronda has spent more than 20 years working in software development in a variety of roles, from strategy execution to building effective teams.

Jeffrey Bissonnette
Senior Director of Genomic Curation

With a background in genetic counseling, Jeffrey brings over a decade of experience in clinical genetics, variant interpretation, and software tools for variant analysis.

Erin McCann
Head of People

Erin McCann is an HR and People leader with 20+ years of diverse experience. She supports startup teams through rapid growth, cultivating inclusive organizational cultures.

Kojo Elenitoba-Johnson, MD
Co-Founder & Advisor

Kojo is the Director for Precision and Computational Diagnostics at University of Pennsylvania Perelman School of Medicine and President of the Association of Molecular Pathology.

Megan Lim, MD, PhD
Co-Founder & Advisor

Megan is the Director of the Hematopathology and Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania.

Our Core Values

Customer &
Patient Centric

We put customers and patients first in everything that we do.

Always Learning

We approach challenges with curiosity & a growth mindset to imagine what can be, not what is.

Data Driven

We ask questions and look to the evidence for answers.


We have confidence in who we are, where we're going, and how we're getting there.


We embody passion, persistence, and aren't afraid of hard work.

Learn how genomic intelligence can impact your organization.